Aimei Health Technology (NASDAQ:AFJK) Announces Quarterly Earnings Results

Aimei Health Technology (NASDAQ:AFJK) announced its quarterly earnings data on Monday. The company reported $0.02 earnings per share for the quarter, FiscalAI reports.

Aimei Health Technology Trading Down 2.5%

NASDAQ:AFJK traded down $1.13 during mid-day trading on Wednesday, hitting $43.86. The stock had a trading volume of 1,888 shares, compared to its average volume of 24,652. Aimei Health Technology has a twelve month low of $6.75 and a twelve month high of $130.37. The stock has a 50-day simple moving average of $34.55 and a two-hundred day simple moving average of $34.89. The company has a market capitalization of $268.40 million, a PE ratio of 208.85 and a beta of 0.46.

Wall Street Analyst Weigh In

AFJK has been the subject of several research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Friday, March 27th. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a research note on Saturday, January 17th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Aimei Health Technology currently has an average rating of “Sell”.

Institutional Investors Weigh In On Aimei Health Technology

A number of large investors have recently modified their holdings of the company. Berkley W R Corp lifted its position in shares of Aimei Health Technology by 5.9% during the 3rd quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock worth $5,101,000 after purchasing an additional 25,294 shares during the last quarter. Clear Street Group Inc. purchased a new position in Aimei Health Technology in the third quarter valued at $691,000. Quarry LP increased its holdings in Aimei Health Technology by 6.4% in the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares during the last quarter. Dakota Wealth Management acquired a new stake in Aimei Health Technology in the fourth quarter valued at $406,000. Finally, Geode Capital Management LLC purchased a new stake in Aimei Health Technology during the 4th quarter worth about $413,000. 45.58% of the stock is owned by hedge funds and other institutional investors.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.